Entopica Therapeutics, Inc. — Form D
Entopica Therapeutics, Inc. of ANDOVER, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-02. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-03-02
- Form: D
- Accession: 0001486011-10-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 1
- Date of first sale: 2009-02-15
- Revenue range: No Revenues
- SEC file number: 021-139167
Issuer
- Name: Entopica Therapeutics, Inc.
- CIK: 0001486011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: C/O ORA, INC., ANDOVER, MA, 01810
- Phone: 978-685-8900
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Stuart B Abelson | Director | Andover, MA |
| Matthew B Chapin | Director | Andover, MA |
| Aron B Shapiro | Director | Andover, MA |
| Stuart B Abelson | Executive Officer | Andover, MA |
| Edmund, Jr. B Polubinski | Executive Officer | Boston, MA |
More